NCT00770835
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Lipoatrophic, Diabetes Mellitus, Type 2, +6 more
- Locations
-
- Padova, Italy
- Pisa, Italy
Clinical trial condition
Glucose Metabolism Disorders
Explore clinical trials studying Glucose Metabolism Disorders. Study availability and eligibility vary by location and protocol.
278 public trials
29 recruiting studies
Glucose Metabolism Disorders trial results
NCT00114855
- Conditions
- Dyslipidemias, Glucose Metabolism Disorders, Hyperlipidemia, +4 more
- Locations
-
- Lipidklinikken, Rikshospitalet Oslo, Norway
NCT01129258
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
- Locations
-
- Pfizer Investigational Site Chula Vista, California, United States
- Pfizer Investigational Site Fountain Valley, California, United States
- Pfizer Investigational Site Miami, Florida, United States
- Pfizer Investigational Site San Antonio, Texas, United States
NCT00770653
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Lipoatrophic, Diabetes Mellitus, Type 2, +7 more
- Locations
-
- Bretten, Baden-Wurttemberg, Germany
- Deggingen, Baden-Wurttemberg, Germany
- Dettenheim, Baden-Wurttemberg, Germany
- Künzelsau, Baden-Wurttemberg, Germany
NCT00770640
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Lipoatrophic, Diabetes Mellitus, Type 2, +6 more
- Locations
-
- Schwetzingen, Baden-Wurttemberg, Germany
- Wiesbaden, Hesse, Germany
- Bottrop, North Rhine-Westphalia, Germany
- Düsseldorf, North Rhine-Westphalia, Germany
NCT00770445
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Lipoatrophic, Diabetes Mellitus, Type 2, +6 more
- Locations
-
- Lichtenfels, Bavaria, Germany
- Hamburg, Free and Hanseatic City of Hamburg, Germany
- Frankfurt am Main, Hesse, Germany
- Kassel, Hesse, Germany
NCT01102673
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
- Locations
-
- Pfizer Investigational Site New Haven, Connecticut, United States
NCT00772174
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Lipoatrophic, Diabetes Mellitus, Type 2, +6 more
- Locations
-
Not specified
NCT00770952
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Lipoatrophic, Diabetes Mellitus, Type 2, +6 more
- Locations
-
- Villingen-Schwenningen, Baden-Wurttemberg, Germany
- Aschaffenburg, Bavaria, Germany
- Ingolstadt, Bavaria, Germany
- Frankfurt am Main, Hesse, Germany
Completed
Efficacy of Pioglitazone and Fortamet Combination Therapy in Subjects With Type 2 Diabetes
NCT00754403
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Lipoatrophic, Diabetes Mellitus, Type 2, +6 more
- Locations
-
Not specified